31 results  1 of 2 

1 A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer
Hyunji Jo, Seung Tae Kim, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Jeong Il Yu, Hee Chul Park, Doo Ho Choi, Yoonah Park, Yong Beom Cho, Jung Wook Huh, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Won Ki Kang
Cancer Res Treat.2023;55(1):189-195.   Published online 2022 June 8     DOI: http://dx.doi.org/10.4143/crt.2021.1527
      
2 Effectiveness of oral fluoropyrimidine monotherapy as adjuvant chemotherapy for high-risk stage II colon cancer
Jung Rae Cho, Keun-Wook Lee, Heung-Kwon Oh, Jin Won Kim, Ji-Won Kim, Duck-Woo Kim, Jee Hyun Kim, Sung-Bum Kang
Ann Surg Treat Res.2022;102(5):271-280.   Published online 2022 May 3     DOI: http://dx.doi.org/10.4174/astr.2022.102.5.271
      
3 Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion
Changhoon Yoo, Chung Ryul Oh, Seung-Tae Kim, Woo Kyun Bae, Hye-Jin Choi, Do-Youn Oh, Myung-Ah Lee, Baek-Yeol Ryoo
Cancer Res Treat.2021;53(2):291-300.   Published online 2020 December 29     DOI: http://dx.doi.org/10.4143/crt.2020.1233
      
4 Polymorphisms in TYMS for Prediction of Capecitabine-Induced Hand-Foot Syndrome in Chinese Patients with Colorectal Cancer
Si-Qi Dong, Tong-Min Wang, Jiang-Bo Zhang, Yong-Qiao He, Wen-Qiong Xue, Zi-Yi Wu, Da-Wei Yang, Lian-Jing Cao, Jing-Wen Huang, Xi-Zhao Li, Pei-Fen Zhang, Xiao-Hui Zheng, Wei-Hua Jia
Cancer Res Treat.2021;53(3):724-732.   Published online 2020 December 2     DOI: http://dx.doi.org/10.4143/crt.2020.457
      
5 Choice of Capecitabine or S1 in Combination with Oxaliplatin based on Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase Expression Status in Patients with Advanced Gastric Cancer
Rong Xu, Xiaolei He, Reyina Wufuli, Ying Su, Lili Ma, Ru Chen, Zhongcheng Han, Fang Wang, Jiang Liu
J Gastric Cancer.2019;19(4):408-416.   Published online 2019 November 13     DOI: http://dx.doi.org/10.5230/jgc.2019.19.e40
      
6 Effectiveness and safety of oral capecitabine in patients with gynecologic cancers
Hang Jo You, Yong Man Kim, Shin Wha Lee, Dae Yeon Kim, Dae Shik Suh, Jong Hyeok Kim, Young Tak Kim, Joo Hyun Nam, Jung Eun Mok
Korean J Gynecol Oncol.2007;18(4):333-340.   Published online 2019 March 12     DOI: http://dx.doi.org/10.3802/kjgo.2007.18.4.333
      
7 Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma
Jiyoung Rhee, Jaemin Jo, Sang-Hoon Han, Jung-Mi Kwon
Ann Dermatol.2019;31(2):201-203.   Published online 2019 February 28     DOI: http://dx.doi.org/10.5021/ad.2019.31.2.201
      
8 Acute Aortic Thrombosis Following Capecitabine Chemotherapy in a Patient with Colon Cancer
Min Kyung Lee, Eun Young Kim, Young Saing Kim, Sun Jin Sym, Jeong Ho Kim
J Korean Soc Radiol.2018;79(3):166-170.   Published online 2018 August 20     DOI: http://dx.doi.org/10.3348/jksr.2018.79.3.166
      
9 Additional 4-week capecitabine during the resting periods after 6-week neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: long-term oncologic outcomes
Sang Woo Park, Jin Soo Kim, Ji Yeon Kim, Kyung Ha Lee
Ann Surg Treat Res.2018;94(6):306-311.   Published online 2018 May 29     DOI: http://dx.doi.org/10.4174/astr.2018.94.6.306
      
10 Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)
In Hae Park, Seock-Ah Im, Kyung Hae Jung, Joo Hyuk Sohn, Yeon Hee Park, Keun Seok Lee, Sung Hoon Sim, Kyong-Hwa Park, Jee Hyun Kim, Byung Ho Nam, Hee-Jun Kim, Tae-Yong Kim, Kyung-Hun Lee, Sung-Bae Kim, Jin-Hee Ahn, Suee Lee, Jungsil Ro
Cancer Res Treat.2019;51(1):43-52.   Published online 2018 February 14     DOI: http://dx.doi.org/10.4143/crt.2017.562
      
11 Perioperative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy in Locally Advanced Gastric Cancer: Safety and Feasibility in an Interim Survival Analysis
Vikas Ostwal, Arvind Sahu, Anant Ramaswamy, Bhawna Sirohi, Subhadeep Bose, Vikas Talreja, Mahesh Goel, Shraddha Patkar, Ashwin Desouza, Shailesh V. Shrikhande
J Gastric Cancer.2017;17(1):21-32.   Published online 2017 March 16     DOI: http://dx.doi.org/10.5230/jgc.2017.17.e3
      
12 Long-term oncologic outcomes of neoadjuvant concurrent chemoradiotherapy with capecitabine and radical surgery in locally advanced rectal cancer: 10-year experiences at a single institution
Kyung Ha Lee, Jin Soo Kim, Ji Yeon Kim
Ann Surg Treat Res.2016;91(4):178-186.   Published online 2016 September 30     DOI: http://dx.doi.org/10.4174/astr.2016.91.4.178
      
13 Long-term Complete Response with Lapatinib Plus Capecitabine in a Patient with HER2-Positive Breast Cancer Metastasized to the Pancreas
Kichul Shin, Jinsu Kim, Seokyoung Yoon, Eung-Ho Cho, Changwon Jung, Hye Jin Kang
Ewha Med J.2015;38(3):138-143.   Published online 2015 October 31     DOI: http://dx.doi.org/10.12771/emj.2015.38.3.138
      
14 Phase I Study of Axitinib in Combination with Cisplatin and Capecitabine in Patients with Previously Untreated Advanced Gastric Cancer
Do-Youn Oh, Toshihiko Doi, Kuniaki Shirao, Keun-Wook Lee, Sook Ryun Park, Ying Chen, Liqiang Yang, Olga Valota, Yung-Jue Bang
Cancer Res Treat.2015;47(4):687-696.   Published online 2015 February 12     DOI: http://dx.doi.org/10.4143/crt.2014.225
      
15 A Randomized Phase II Trial of Capecitabine Plus Vinorelbine Followed by Docetaxel Versus Adriamycin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy for Breast Cancer
Changhoon Yoo, Sung-Bae Kim, Jin-Hee Ahn, Jeong Eun Kim, Kyung Hae Jung, Gyung-Yub Gong, Byung-Ho Son, Sei-Hyun Ahn, Seung Do Ahn, Hak-Hee Kim, Hee Jung Shin, Woo Kun Kim
Cancer Res Treat.2015;47(3):406-415.   Published online 2014 November 24     DOI: http://dx.doi.org/10.4143/crt.2014.073
      
16 Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer
Jieun Lee, Tae Ho Hong, In Seok Lee, Young Kyoung You, Myung Ah Lee
Cancer Res Treat.2015;47(2):259-265.   Published online 2014 September 12     DOI: http://dx.doi.org/10.4143/crt.2013.230
      
17 Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer
Jae Yun Lim, Jang Ho Cho, Se Joon Lee, Dong Ki Lee, Dong Sup Yoon, Jae Yong Cho
Cancer Res Treat.2015;47(2):266-273.   Published online 2014 August 29     DOI: http://dx.doi.org/10.4143/crt.2013.158
      
18 Changes in the Mean Corpuscular Volume after Capecitabine Treatment Are Associated with Clinical Response and Survival in Patients with Advanced Gastric Cancer
Hyun Ae Jung, Hyun-Jun Kim, Chi Hoon Maeng, Se Hoon Park, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang
Cancer Res Treat.2015;47(1):72-77.   Published online 2014 August 21     DOI: http://dx.doi.org/10.4143/crt.2013.172
      
19 Differential Diagnosis between Hand-foot Syndrome and Gout in Colorectal Cancer with Capecitabine: A Case Study and Review of the Literature
Jeong Yun Park
Asian Oncol Nurs.2014;14(1):1-6.   Published online 2014 March 31     DOI: http://dx.doi.org/10.5388/aon.2014.14.1.1
      
20 Prolonged Regression of Metastatic Leptomeningeal Breast Cancer That Has Failed Conventional Therapy: A Case Report and Review of the Literature
Andrew Vincent, Glenn Lesser, Doris Brown, Tamara Vern-Gross, Linda Metheny-Barlow, Julia Lawrence, Michael Chan
J Breast Cancer.2013;16(1):122-126.   Published online 2013 March 31     DOI: http://dx.doi.org/10.4048/jbc.2013.16.1.122
      

 1 of 2